REFLECT SCIENTIFIC, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data REFLECT SCIENTIFIC, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2021	FY2022	FY2023
Revenue	1.53	1.04	1.19	1.07	1.55	1.61	2.79	2.81	2.04	1.08
Cost of revenue	0.68	0.41	0.38	0.41	0.49	0.62	1.07	0.88	0.82	0.48
Gross profit	0.85	0.63	0.81	0.66	1.06	0.99	1.72	1.93	1.22	0.6
Research and development	0.02	0.07	0.07	0.05	0.1	0.21	0.19	0.06	0.07	0.03
Selling and marketing								0.02	0.08	0.05
General and administrative	0.68	0.32	0.34	0.33	0.62	0.41	0.35	0.44	0.42	0.39
Operating expenses	1.57	1.09	1.06	1.06	1.31	1.19	1.07	1.1	1.13	1.06
Operating income	-0.72	-0.46	-0.25	-0.4	-0.25	-0.19	0.65	0.83	0.09	-0.47
Interest expense	-0.12	-0.06	-0	0	-0	-0	0
Other non-operating income	-0.12	1.3	0.04	0						0.01
Pre-tax income	-0.84	0.84	-0.22	-0.4	-0.25	-0.2	0.66	0.94	0.09	-0.46
Income tax	0	0	0	0	0	0			0	0
Net income	-0.84	0.84	-0.22	-0.4	-0.25	-0.2	0.66	0.94	0.09	-0.46
EBITDA	-0.72	-0.46	-0.25	-0.4	-0.25	-0.19	0.65	0.83
EPS, basic	-0.01	0.02	0.00	-0.01	0.00	0.00	0.04	0.01	0.00	-0.01
EPS, diluted	-0.01	0.01	0.00	-0.01	0.00	0.00	0.01	0.01	0.00	-0.01
Shares, basic (weighted)	108	58.2	63	66.3	74.6		84.7	84.7	85	85.2
Shares, diluted (weighted)	108	58.2	63	66.3	74.6		84.7	85.5	85.4	85.2

Balance sheet

	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2021	FY2022	FY2023
Cash and equivalents	0.27	0.29	0.26	0.24	0.22	0.56	0.64	1.47	1.38	1.28
Receivables							0.34	0.18	0.13	0.11
Inventory	0.22	0.21	0.16	0.14	0.25		0.44	0.62	0.8	0.97
Other current assets	0	0	0	0	0.03		0.02	0.03	0.02	0.01
Total current assets	0.75	0.64	0.52	0.52	0.95		1.45	2.31	2.33	2.37
Property, plant and equipment	0	0	0	0.01	0
Lease right-of-use assets				0	0.06		0.17	0.11	0.05	0.24
Goodwill	0.06	0.06	0.06	0.06	0.06		0.06	0.06	0.06	0.06
Intangible assets	0.03	0.01	0	0	0
Other non-current assets										0
Total assets	0.84	0.71	0.58	0.59	1.08		1.68	2.48	2.45	2.67
Accounts payable			0.05	0.05	0.11		0.07	0.07	0.06	0.06
Accrued liabilities	0.01	0
Deferred revenue							0.11	0.06
Total current liabilities	1.41	0.15	0.12	0.07	0.51		0.24	0.24	0.15	0.6
Lease liabilities				0	0.01		0.11	0.06		0.18
Total liabilities	1.41	0.15	0.12	0.07	0.53		0.46	0.3	0.15	0.78
Paid-in capital	19.1	19.4	19.8	20	20.2		20.2	20.2	20.3	20.3
Retained earnings	-20.3	-19.4	-20.1	-20.3	-20.5	-20.5	-19.8	-18.9	-18.8	-19.3
Shareholders' equity	-0.57	0.55	0.46	0.52	0.55	0.55	1.21	2.18	2.3	1.89
Total equity	-0.57	0.55	0.57	0.46	0.52	0.55	1.21	2.18	2.3	1.89
Total liabilities and equity	0.84	0.71	0.58	0.59	1.08		1.68	2.48	2.45	2.67
Shares outstanding	113	61	65.4	71.3	79.1	84.7	84.7	85	85.2	85.7

Cash flow statement

	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2021	FY2022	FY2023
Net income	-0.84	0.84	-0.22	-0.4	-0.25	-0.2	0.66	0.94	0.09	-0.46
Depreciation and amortization	0	0	0	0	0	0	0	0
Stock-based compensation	0.42	0.26	0.2	0.23				0.03	0.03	0.06
Change in receivables	0.1	-0.12	-0.06	0.05	0.03	-0.04	-0.22	0.16	0.05	0.02
Change in inventory	-0.1	-0.01	0.02	-0.07	-0.01	0.11	-0.19	-0.19	-0.17	-0.17
Change in payables	0.03	0.05	-0.03	-0.01	-0	0.06	-0.04	-0	0.01	0.01
Cash from operations	0.11	0.03	-0.02	-0.03	-0.01	0.34	-0.03	0.83	-0.09	-0.1
Cash from investing	0	0	0	0	-0.01	0
Debt issued							0.11
Cash from financing	-0.09	-0.01	-0.01	0	0.01	-0	0.11
Net change in cash	0.02	0.02	-0.03	-0.03	-0.02	0.33	0.09	0.83	-0.09	-0.1
Interest paid	0.01	0	0	0	0	0	0
Income taxes paid	0	0	0	0	0	0		0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2024; growth uses fiscal years. Valuation uses the share price of $0.06 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	58.5%	Gross profit / revenue.
Operating margin	-3.6%	Operating income / revenue.
Pre-tax margin	-2.3%	Pre-tax income / revenue.
Net margin	-1.7%	Net income / revenue.
Operating cash flow margin	-18.0%	Cash from operations / revenue.
Return on equity (ROE)	-1.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.3%	Net income / average total assets.
Return on invested capital (ROIC)	-4.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.4%	Research and development expense / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-47.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-27.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-7.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-51.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-29.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-10.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-618.6%	Operating income vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-613.5%	Net income vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-17.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	16.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	27.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	9.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	16.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	19.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	15.0x	Current assets / current liabilities.
Quick ratio	9.35x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	7.40x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	11.1%	Total liabilities / total assets.
Working capital	$2.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	2.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.74x	Revenue / average total assets.
Inventory turnover	0.92x	Cost of revenue / average inventory.
Days inventory	396 days	365 x average inventory / cost of revenue.
Receivables turnover	6.33x	Revenue / average receivables.
Days sales outstanding	58 days	365 x average receivables / revenue.
Days payables	31 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	422 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.02	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.00	Cash from operations / diluted weighted shares.
Book value per share	$0.02	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.02	Tangible book value / shares outstanding.
Cash per share	$0.01	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$5.4M	Share price x shares outstanding.
Enterprise value	$4.4M	Market cap + total debt - cash - short-term investments.
P/S	3.13x	Market cap / revenue.
P/B	2.60x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.67x	Market cap / tangible book value, when positive.
EV/Sales	2.54x	Enterprise value / revenue.
Earnings yield	-0.5%	Net income / market cap (the inverse of P/E).

What was REFLECT SCIENTIFIC, INC.'s revenue in fiscal 2023?

REFLECT SCIENTIFIC, INC. reported revenue of $1.1M for fiscal 2023, 47.1% lower than the year before.

Was REFLECT SCIENTIFIC, INC. profitable in fiscal 2023?

No. It reported a net loss of $459.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to REFLECT SCIENTIFIC, INC.